Vlado Perkovic's Publications

• A meta-analysis of GFR slope as a surrogate endpoint for kidney failure

  Journal articles

  2023

  Nature Medicine

• Effects of newer kidney protective agents on kidney endpoints provide implications for future clinical trials

  Journal articles

  2023

  Kidney International

• Effects of canagliflozin on cardiovascular and kidney events in patients with chronic kidney disease with and without peripheral arterial disease: Integrated analysis from the CANVAS Program and CREDENCE trial

  Journal articles

  2023

  Diabetes, Obesity and Metabolism

• Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial

  Journal articles

  2023

  American Journal of Kidney Diseases

• A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF BION-1301 IN ADULTS WITH IGA NEPHROPATHY

  Conference Papers

  2023

  NEPHROLOGY DIALYSIS TRANSPLANTATION

• HEART FAILURE IN ASCEND-ND AND ASCEND-D

  Conference Papers

  2023

  NEPHROLOGY DIALYSIS TRANSPLANTATION

• 3807 HEART FAILURE IN ASCEND-ND AND ASCEND-D

  Journal articles

  2023

  Nephrology Dialysis Transplantation

• 4333 A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF BION-1301 IN ADULTS WITH IGA NEPHROPATHY

  Journal articles

  2023

  Nephrology Dialysis Transplantation

• Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering

  Journal articles

  2023

  BMJ Open Diabetes Research and Care

• Glycemic Control and Effects of Canagliflozin in Reducing Albuminuria and eGFR: A Post Hoc Analysis of the CREDENCE Trial

  Journal articles

  2023

  Clinical journal of the American Society of Nephrology : CJASN

• Design and population of the VALOR-CKD study: a multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of veverimer in slowing progression of chronic kidney disease in patients with metabolic acidosis

  Journal articles

  2023

  Nephrology Dialysis Transplantation

• Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

  Journal articles

  2023

  The Lancet

• IgA Nephropathy Patient Baseline Characteristics in the Sparsentan PROTECT Study

  Journal articles

  2023

  Kidney International Reports

• Targeting the Alternative Complement Pathway With Iptacopan to Treat IgA Nephropathy: Design and Rationale of the APPLAUSE-IgAN Study

  Journal articles

  2023

  Kidney International Reports

• Effects of canagliflozin on liver steatosis and fibrosis markers in patients with type 2 diabetes and chronic kidney disease: A post hoc analysis of the CREDENCE trial

  Journal articles

  2023

  Diabetes, Obesity and Metabolism

• Glucocorticoids for IgA nephropathypro

  Journal articles

  2023

  Kidney International

• National health policies and strategies for addressing chronic kidney disease: Data from the International Society of Nephrology Global Kidney Health Atlas

  Journal articles

  2023

  PLOS Global Public Health

• Treatment effect of canagliflozin for patients on therapy for heart failure: Pooled analysis of the CANVAS program and CREDENCE trial

  Journal articles

  2023

  International Journal of Cardiology

• LONG-TERM SAFETY OF HYPOXIA INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITORS IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS

  Conference Papers

  2023

  NEPHROLOGY

• Design and Baseline Characteristics of the FIND-CKD Trial: Efficacy of Finerenone on Kidney Disease Progression in People with Non-Diabetic CKD

  Journal articles

  2023

  Journal of the American Society of Nephrology

• External Validation of a Machine Learning Model for Progression of CKD in the CREDENCE and CANVAS Trials

  Journal articles

  2023

  Journal of the American Society of Nephrology

• The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset

  Journal articles

  2023

  Journal of the American Society of Nephrology

• Long-Term Safety of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in CKD: A Systematic Review and Meta-Analysis of Randomized Trials

  Journal articles

  2023

  Journal of the American Society of Nephrology

• The prevalence of chronic kidney disease in Australian primary care: analysis of a national general practice dataset

  Preprints

  2023

• Estimating the population-level kidney benefits of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease in Australian primary care

  Preprints

  2023

• WCN23-0069 EFFICACY AND SAFETY OF REDUCED-DOSE ORAL METHYLPREDNISOLONE IN IGA NEPHROPATHY: THE TESTING TRIAL

  Journal articles

  2023

  Kidney International Reports